11 Implications for the Future
6. Polypharmacy and service use
The role of polypharmacy in the consumption of health services requires more research as unnecessary polypharmacy may cause adverse drug effects or other harms linked to drug treatment that may lead to increased use of health services.
12 References
1. National Agency for Medicines and Social Insurance Institution: Finnish Statistics on Medicines 2008. Edita Prima Oy, Helsinki 2009
2. Statistics Finland: Population structure 2008: The population of Finland in 2008. Official Statistics of Finland, 2009. Retrieved 9 February 2011 from:
http://www.stat.fi/til/vaerak/2008/ vaerak_2008_2009-03-27_en.pdf
3. Statistics Finland: Population by age 1900–2060 (years 2010 to 2060:
projection). Population Statistics, 2009. Retrieved 9 February 2011 from http://www.stat.fi/til/vaenn/2009/vaenn_2009_2009-09-30_tau_001_en.html
4. Larsson K, Thorslund M: Chapter 8: Old people's health. Scand J Public Health 34 (67 suppl):185–198, 2006
5. Zurakowski T: The practicalities and pitfalls of polypharmacy. Nurse Pract 34(4):36–41, 2009
6. Cooper JW: Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J Am Geriatr Soc 44:194–197, 1996
7. Field TS, Gurwitz JH, Avorn J, et al.: Risk factors for adverse drug events among nursing home residents. Arch Intern Med 161:1629–163, 2001
8. Field TS, Gurwitz JH, Harrold LR, et al.: Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 52:1349–1354, 2004
9. Hanlon JT, Artz MB, Pieper CF, et al.: Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 38:9–14, 2004
10. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ: Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54:1516–1523, 2006
11. Rossi MI, Young A, Maher R, et al.: Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother 5:317–323, 2007
12. Martikainen JE, Enlund H: New chemical entities and their market penetration in Finland during the years 1996 through 2005. Clin Ther 31:668–
676, 2009
13. Lernfelt B, Samuelsson O, Skoog I, Landahl S: Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 59:637–644, 2003
14. Haider SI, Johnell K, Thorslund M, Fastbom J: Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther 45:643–653, 2007
15. Ruokoniemi P, Helin-Salmivaara A, Klaukka T, Neuvonen PJ, Huupponen R: Shift of statin use towards the elderly in 1995–2005: a nation-wide register study in Finland. Br J Clin Pharmacol 66:405–410, 2008
16. Birren JE, Schaie KW: Handbook of the Psychology of Aging. 5th edition.
Academic press, San Diego: California 2001
17. Armour D, Cairns C: Medicines in the Elderly. 1st edition. Pharmaceutical Press, London 2002
18. Hooyman NR, Kiyak HA: Social Gerontology: a multidisciplinary perspective. 8th edition. Allyn & Bacon, Needham Heights: Massaschusetts 2008
19. Taylor P, Morin R, Parker K, Cohn D, Wang W: Growing old in America:
Expectations vs. Reality. PewResearchCenter. A social & demographic trends report, 2009. Retrieved 9 February 2011 from
http://pewsocialtrends.org/files/2010/10/Getting-Old-in-America.pdf
20. Social Insurance Institution (SII): Statistical Yearbook of the Social Insurance Institution 2009. Official Statistics of Finland. Vammalan kirjapaino, Sastamala 2010
21. Statistics Finland: Official Statistics of Finland, 2010. Retrieved 9 February 2011 from http://tilastokeskus.fi/til/index_en.html
22. Hodgkins Berardo D: Social and psycholocical issues in aging and health.
In: Therapeutics in the elderly, pp. 31–50, 2nd edition. Eds. Delafuente JC, Stewart RB, Harwey Whitney Books Company, Cincinnati:Ohio 1995
23. Frazier SC: Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 31:4–11, 2005
24. Fulton MM, Allen ER: Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 17:123–132, 2005
25. Hajjar ER, Cafiero AC, Hanlon JT: Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5:345–351, 2007
26. Michocki RJ: Polypharmacy and principles of drug therapy. In: 20 common problems in geriatrics, pp. 69–81, 1st edition. Eds. Adelman AM, Daly MP, MCGraw-Hill Companies, New York: New York 2001
27. Larsen PD, Hoot Martin JL: Polypharmacy and elderly patients. AORN Journal 69:619–628, 1999
28. Brager R, Sloand E: The spectrum of polypharmacy. Nurse Pract 30(6):44–
50, 2005
29. Chen LH, Liu S, Newell ME, Barnes K: Survey of drug use by the elderly and possible impact of drugs on nutritional status. Drug Nutr Interact 3:73–86, 1985
30. Gilchrist WJ, Lee YC, Tam HC, Macdonald JB, Williams BO: Prospective study of drug reporting by general practitioners for an elderly population referred to a geriatric service. Br Med J 294:289–290, 1987
31. Cartwright A: Collecting data about drug use by elderly persons.
Pharmaceutish Weekblad Scientific Edition 12:60–65, 1990
32. Kroenke K, Pinholt EM: Reducing polypharmacy in the elderly. A controlled trial of physician feedback. J Am Geriatr Soc 38:31–36, 1990
33. Lassila HC, Stoehr GP, Ganguli M, et al.: Use of prescription medications in an elderly rural population: the MoVIES Project. Ann Pharmacother 30:589–
595, 1996
34. Jörgensen T, Johansson S, Kennerfalk A, Wallander MA, Svärdsudd K:
Prescription drug use, diagnoses, and healthcare utilization among the elderly.
Ann Pharmacother 35:1004–1009, 2001
35. Kennerfalk A, Ruigomez A, Wallander MA, Wilhelmsen L, Johansson S:
Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 36:797–803, 2002
36. Neutel CI, Perry S, Maxwell C: Medication use and risk of falls.
Pharmacoepidemiol Drug Saf 11:97–104, 2002
37. Lawlor DA, Patel R, Ebrahim S: Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 327:712–717, 2003
38. Odubanjo E, Bennett K, Feely J: Influence of socioeconomic status on the quality of prescribing in the elderly – a population based study. Br J Clin Pharmacol 58:496–502, 2004
39. Hajjar ER, Hanlon JT, Sloane RJ, et al.: Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 53:1518–1523, 2005
40. Snowdon J, Day S, Baker W: Audits of medication use in Sydney nursing homes. Age Ageing 35:403–408, 2006
41. Green JL, Hawley JN, Rask KJ: Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 5:31–39, 2007
42. Johnell K, Klarin I: The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 30:911–918, 2007
43. Linton A, Garber M, Fagan NK, Peterson MR: Examination of multiple medication use among TRICARE beneficiaries aged 65 years and older. J Manag Care Pharm 13:155–162, 2007
44. Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J: The Influence of Educational Level on Polypharmacy and Inappropriate Drug Use: A Register-Based Study of More Than 600,000 Older People. J Am Geriatr Soc 57:62–69, 2009
45. Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA, OLDY (OLd people Drugs & dYsregulations) Study Group: Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 65:130–133, 2008
46. Chan DC, Hao YT, Wu SC: Polypharmacy among disabled Taiwanese elderly: a longitudinal observational study. Drugs Aging 26:345–354, 2009
47. Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S:
Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord 24:56–63, 2010
48. Lam DP, Mak CF, Chan SM, Yao RW, Leung SS, You JH: Polypharmacy and inappropriate prescribing in elderly Hong Kong Chinese patients. J Am Geriatr Soc 58:203–205, 2010
49. Harugeri A, Joseph J, Parthasarathi G, Dip G, Ramesh M, Guido S:
Prescribing patterns and predictors of high-level polypharmacy in the elderly population: a prospective surveillance study from two teaching hospital in India. Am J Ger Pharmacother 8:271–280, 2010
50. Rørvik FB, Laake K: Medisinering hos pensjonærer i alders- og sykehjem.
Tidssker Nor Lækeforen 110:1335–1338, 1990
51. Jylhä M: Ten-year change in the use of medical drugs among the elderly – a longitudinal study and cohort comparison. J Clin Epidemiol 47:69–79, 1994
52. Nobili A, Tettamanti M, Frattura L, et al.: Drug use by the elderly in Italy.
Ann Pharmacother 31:416–422, 1997
53. Barat I, Andreasen F, Damsgaard EM: The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 56:501–
509, 2000
54. Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE: Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 55:M554–559, 2000
55. Chen YF, Dewey ME, Avery AJ, Analysis Group of The MRCCFA Study:
Self-reported medication use for older people in England and Wales. J Clin Pharm Ther 26:129–140, 2001
56. Pitkälä KH, Strandberg TE, Tilvis RS: Is it possible to reduce polypharmacy in the elderly? A randomised, controlled trial. Drugs Aging 18:143–149, 2001
57. Arslan S, Atalay A, Gokce-Kutsal Y: Drug use in older people. J Am Geriatr Soc 50:1163–1164, 2002
58. Agostini JV, Han L, Tinetti ME: The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc 52:1719–1723, 2004
59. Klarin I, Wimo A, Fastbom J: The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old.
Drugs Aging 22:69–82, 2005
60. Lindblad CI, Artz MB, Pieper CF, et al.: Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother 39:412–417, 2005
61. Junius-Walker U, Theile G, Hummers-Pradier E: Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 24:14–19, 2007
62. Moen J, Antonov K, Larsson CA, et al.: Factors associated with multiple medication use in different age groups. Ann Pharmacother 43:1978–1985, 2009
63. Crentsil V, Ricks MO, Xue QL, Fried LP: A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use. Am J Geriatr Pharmacother 8:215–224, 2010
64. Bjerrum L, Søgaard J, Hallas J, Kragstrup J: Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 54:197–202, 1998
65. Thomas HF, Sweetnam PM, Janchawee B, Luscombe DK: Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 55:411–415, 1999
66. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM: The development of polypharmacy. A longitudinal study. Fam Pract 17:261–267, 2000
67. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA: Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287:337–344, 2002
68. Sloane Epidemiology Center: Patterns of medication use in the United States, 2006: a report from the Sloane Survey. Boston University, 2006.
Retrieved 9 February 2011 from http://www.bu.edu/slone/SloneSurvey/
AnnualRpt/SloneSurveyWebReport2006.pdf
69. Rajska-Neumann A, Wieczorowska-Tobis K: Polypharmacy and potential inappropriateness of pharmaco-logical treatment among commuinity-dwellling elderly patients. Arch Gerontol Geriatr 44 (Suppl 1):303–309, 2007
70. Gallagher PF, Barry PJ, Ryan C, Hartigan I, O'mahony D: Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing 37:96–101, 2007
71. World Health Organization (WHO): Drugs for the Elderly. WHO Regional Publications, European Series, No. 71, 2nd edition. Ed. Offerhaus L, WHO Regional Office for Europe, Copenhagen 1997
72. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN:
Polypharmacy: misleading, but manageable. Clin Interv Aging 3:383–389, 2008
73. Landahl S: Drug treatment in 70–82-year-old persons. A longitudinal study. Acta Med Scand 221:179–184, 1987
74. Stewart RB, Moore MT, May FE, Marks RG, Hale WE: A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epimiol 44:1353–1359, 1991
75. Martikainen J, Enlund H, Tuovinen K, Nissinen A: Changes in drug use among elderly men over a five-year period. J Appl Ther 1:171–177, 1996
76. Fillenbaum GG, Horner RD, Hanlon JT, Landerman LR, Dawson DV, Cohen HJ: Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. J Clin Epidemiol 49:587–593, 1996
77. Klaukka T, Martikainen J, Kalimo E: Drug utilization in Finland 1964–1987.
Publications of the Social Insurance Institution M:71. The Reseach Institute for Social Security, Helsinki 1990
78. Hsu RY, Lin MS, Chou MH, Lin MF: Medication use characteristics in an ambulatory elderly population in Taiwan. Ann Pharmacother 31:308–314, 1997
79. Giron MST, Claesson C, Thorslund M, Oke T, Winblad B, Fastbom J: Drug use pattern in a very elderly population: a seven-year review. Clin Drug Invest 17:389–398, 1999
80. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä SL, Isoaho R: Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55:809–817, 2002
81. Janzing JG, van 't Hof MA, Zitman FG: Drug use and cognitive function in residents of homes for the elderly. Pharm World Sci 19:279–282, 1997
82. Stuart B, Kamal-Bahl S, Briesacher B, et al.: Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. Am J Geriatr Pharmacother 1:61–74, 2003
83. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST:
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 300:2867–2878, 2008
84. World Health Organization: ATC/DDD – International language for drug utilization research. WHO Collarborating Centre for Drug Statistics Methodology. Oslo, Norway 2010. Retrieved 9 February 2011 from http://www.whocc.no/
85. Poole C, Jones D, Veitch B: Relationships between prescription and non-prescription drug use in an elderly population. Arch Gerontol Geriatr 28:259–
271, 1999
86. Thomas E, Boardman HF, Croft PR: Why do older people report fewer headaches? Gerontology 51:322–328, 2005
87. Nguyen JK, Fouts MM, Kotabe SE, Lo E: Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4:36–41, 2006
88. Jörgensen TM, Isacson DG, Thorslund M: Prescription drug use among ambulatory elderly in a Swedish municipality. Ann Pharmacother 27:1120–
1125, 1993
89. Klaukka T, Mäkelä M, Sipilä J, Martikainen J: Multiuse of medicines in Finland. Med Care 31:445–450, 1993
90. Cannon KT, Choi MM, Zuniga MA: Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 4:134–143, 2006
91. Vener AM, Krupka LR, Climo JJ: Drug usage and health characteristics in noninstitutional retired persons. J Am Geriatr Soc 27:83–90, 1979
92. Cadigan DA, Magaziner J, Fedder DO: Polymedicine use among community resident older women: how much a problem? Am J Public Health 79:1537–1540, 1989
93. Chrischilles A, Foley J, Wallace B, et al.: Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol 47:137–144, 1992
94. Laukkanen P, Heikkinen E, Kauppinen M, Kallinen M: Use of drugs by non-institutionalized urban Finns born in 1904–1923 and the association of drug use with mood and self-rated health. Age Ageing 21:343-352, 1992
95. Tordoff JM, Bagge ML, Gray AR, Campbell AJ, Norris PT: Medicine-taking practices in community-dwelling people aged ≥75 years in New Zealand. Age Ageing 39:574–580, 2010
96. Lindberg J, Claesson CB, Cornelius C, Fratiglioni L, Thorslund M, Winblad B: Medicine use in the elderly. A population-based study in urban areas of Sweden. Drug Invest 8:241–253, 1994
97. Stoller EP: Prescribed and over-the-counter medicine use by the ambulatory elderly. Med Care 26:1149–1157, 1988
98. Gray SL, Mahoney JE, Blough DK: Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 35:539–545, 2001
99. Doshi JA, Shaffer T, Briesacher BA: National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey. J Am Geriatr Soc 53:438–443, 2005
100. Bernadotte af Wisborg G, Claesson CB, Lundberg O, Thorslund M: Drug usage and self-reported health among a cross-sectional population aged 75 years. Clin Drug Invent 12:166–170, 1996
101. Pilotto A, Franceschi M, Vitale D, et al.: Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms. Eur J Clin Pharmacol 62:65–73, 2006
102. Christopher LJ, Ballinger BR, Shepherd AM, Ramsay A, Crooks G: Drug prescribing patterns in the elderly: a cross-sectional study of in-patients. Age Ageing 7:74–82, 1978
103. Claesson CB, Schmidt IK: Drug use in Swedish nursing homes. Clin Drug Invest 16:441–452, 1998
104. Hale WE, May FE, Marks RG, Stewart RB: Drug use in an ambulatory elderly population: a five-year update. Drug Intell Clin Pharm 21:530–535, 1987
105. Haider SI, Johnell K, Thorslund M, Fastbom J: Analysis of the association between polypharmacy and socioeconomic position among elderly aged ≥77 years in Sweden. Clin Ther 30:419–427, 2008
106. Hiitola PK, Enlund H, Sulkava RO, Hartikainen SA: Changes in the use of cardiovascular medicines in the elderly aged 75 years or older – a population-based Kuopio 75+ Study. J Clin Pharm Ther 32:253–259, 2007
107. Schuler J, Duckelmann C, Beindl W, Prinz E, Michalski T, Pichler M:
Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr 120:733–741, 2008
108. Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA: Polypharmacy in nursing home residents in the United States: Results of the 2004 National Nursing Home Survey. Am J Ger Pharmacother 8:63–72, 2010
109. Hartikainen S, Rahkonen T, Kautiainen H, Sulkava R: Kuopio 75+ study:
does advanced age predict more common use of psychotropics among the elderly? Int Clin Psychopharmacol 18:163–167, 2003
110. Wills P, Claesson CB, Fratiglioni L, Fastbom J, Thorslund M, Winblad B:
Drug use by demented and non-demented elderly people. Age Ageing 26:383–
391, 1997
111. Bergman A, Olsson J, Carlsten A, Waern M, Fastbom J: Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 25:9–14, 2007
112. Somers M, Rose E, Simmonds D, Whitelaw C, Calver J, Beer C: Quality use of medicines in residential aged care. Aust Fam Physician 39:413–416, 2010
113. Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA:
Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry 14:280–284, 1999
114. Roberts MS, King M, Stokes JS, et al.: Medication prescribing and administration in nursing homes. Age Ageing 27:385–392, 1998
115. Hale WE, Marks RG, Stewart RB: Drug use in a geriatric population. J Am Geriatr Soc 27:374–377, 1979
116. May FE, Stewart RB, Hale WE, Marks RG: Prescribed and nonprescribed drug use in an ambulatory elderly population. South Med J 75:522–528, 1982
117. Mas X, Laporte JR, Frati ME, et al.: Drug prescribing and use among elderly people in Spain. Drug Intell Clin Pharm 17:378–382, 1983
118. Passmore AP, Crawford VLS, Beringer TRO, Gilmore DH, Montgomery A: Determinants of drug utilization in an elderly population in north and west Belfast. Pharmacoepidemiol Drug Saf 4:147–160, 1995
119. Pokela N, Bell JS, Lihavainen K, Sulkava R, Hartikainen S: Analgesic use among community-dwelling people aged 75 years and older: A population-based interview study. Am J Geriatr Pharmacother 8:233–244, 2010
120. Iwata M, Kuzuya M, Kitagawa Y, Suzuki Y, Iguchi A: Underappreciated predictors for postdischarge mortality in acute hospitalized oldest-old patients. Gerontology 52:92–98, 2006
121. Baranzini F, Diurni M, Ceccon F, et al.: Fall-related injuries in a nursing home setting: is polypharmacy a risk factor? BMC Health Serv Res 9:228, 2009 (open access journal). Retrieved 9 February 2011 from http://www.biomedcentral.com/1472-6963/9/228
122. Sawyer P, Bodner EV, Ritchie CS, Allman RM: Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacother 4:316–
324, 2006
123. Ruby CM, Fillenbaum GG, Kuchibhatla MN, Hanlon JT: Laxative use in the community-dwelling elderly. Am J Geriatr Pharmacother 1:11–17, 2003
124. Suominen MH, Hosia-Randell HM, Muurinen S, et al.: Vitamin D and calcium supplementation among aged residents in nursing homes. J Nutr Health Aging 11:433–437, 2007
125. Dunnell K, Cartwright A: Medicine takers, prescribers and hoarders.
Social Studies in Medical Care. Reports of the Institute for Social Studies in Medical Care. Routledge&Kegan Paul, Boston 1972
126. Lundin DV: Medication taking behavior of the elderly: a pilot study. Drug Intell Clin Pharm 12:518–522, 1978
127. Ostrom JR, Hammarlund ER, Christensen DB, Plein JB, Kethley AJ:
Medication usage in an elderly population. Med Care 23:157–164, 1985
128. Turakka H, Enlund H: Drug use and prescription compliance by elderly persons. J Clin Pharm 3:103–112, 1978
129. Enlund H: Vanhusten lääkkeiden käyttö. In: Vanhuuden kokeminen Kuopiossa, pp. 68–77. Ed. Lauri S, Publications of the University of Kuopio, Social Sciences, Statistics and Reviews 2/1988, Kuopio 1988 (In Finnish)
130. Col N, Fanale JE, Kronholm P: The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150:841–845, 1990
131. Noro A, Häkkinen U, Arinen S: Health, functional ability and use of health and social services among ageing Finns in 1996: Findings of surveys of persons living in long-term care institutions and at home. Official Statistics of Finland, Health 2000:2. STAKES and Social Insurance Institution, Helsinki 2000
132. Schmader KE, Hanlon JT, Pieper CF, et al.: Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 116:394–401, 2004
133. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L: Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 63:177–186, 2007
134. Radosević N, Gantumur M, Vlahović-Palcevski V: Potentially inappropriate prescribing to hospitalised patients. Pharmacoepidemiol Drug Saf 17:733–737, 2008
135. Turakka H, Enlund H, Martikainen L: Eläkeikäisten lääkkeiden käyttö Kuopiossa. In: Vanheneminen ja vanhusten huolto [Aging and care of the elderly], pp 207–211, Eds. Sahi T, Heikkinen E, Huunan-Seppälä A, Kalimo E, Publications of the Social Insurance Institution A:16, Helsinki 1981 (In Finnish)
136. Enlund H, Martikainen J, Turakka H, Nissinen A: The use of prescription drugs among elderly Finnish men. J Clin Pharm Ther 15:115–122, 1990
137. Campbell AJ, McCosh L, Reinken J: Drugs taken by a population based sample of subjects 65 years and over in New Zealand. N Z Med J 96:378–380, 1983
138. Gupta S, Rappaport HM, Bennett LT: Polypharmacy among nursing home geriatric Medicaid recipients. Ann Pharmacother 30:946–950, 1996
139. Fillit HM, Futterman R, Orland BI, et al.: Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 5:587–594, 1999
140. Tromp AM, Pluijm SM, Smit JH, Deeg DJ, Bouter LM, Lips P: Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol 54:837–844, 2001
141. Fialová D, Onder G: Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol 67:641–645, 2009
142. Kuzuya M, Masuda Y, Hirakawa Y, et al.: Underuse of medications for chronic diseases in the oldest of community-dwelling older frail Japanese. J Am Geriatr Soc 54:598–605, 2006
143. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC: Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine 89:295–299, 2010
144. Gokce Kutsal Y, Barak A, Atalay A, et al.: Polypharmacy in the elderly: a multicenter study. J Am Med Dir Assoc 10:486–490, 2009
145. Saltvedt I, Spigset O, Ruths S, Fayers P, Kaasa S, Sletvold O: Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. Eur J Clin Pharmacol
145. Saltvedt I, Spigset O, Ruths S, Fayers P, Kaasa S, Sletvold O: Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. Eur J Clin Pharmacol